首页> 外文期刊>Archives of dermatological research. >Colloidal carriers of isotretinoin for topical acne treatment: skin uptake, ATR-FTIR and in vitro cytotoxicity studies
【24h】

Colloidal carriers of isotretinoin for topical acne treatment: skin uptake, ATR-FTIR and in vitro cytotoxicity studies

机译:异维A酸的胶体载体用于局部痤疮的治疗:皮肤吸收,ATR-FTIR和体外细胞毒性研究

获取原文
获取原文并翻译 | 示例
           

摘要

Acne vulgaris is the chronical, multifactorial and complex disease of the pilosebaceous unit in the skin. The main goal of the topical therapy in acne is to target the drug to epidermal and deep dermal regions by minimizing systemic absorption . Isotretinoin, a retinoic acid derivative, is the most effective drug in acne pathogenesis. Because systemic treatment may cause many side effects, topical isotretinoin treatment is an option in the management of acne. However, due to its high lipophilic character, isotretinoin tends to accumulate in the upper stratum corneum, thus its penetration into the lower layers is limited, which restricts the efficiency of topical treatment. Microemulsions are fluid, isotropic, colloidal drug carriers that have been widely studied as drug delivery systems. The percutaneous transport of active agents can be enhanced by microemulsions when compared with their conventional formulations. The purpose of this study was to evaluate microemulsions as alternative topical carriers for isotretinoin with an objective to improve its skin uptake. After in vitro permeation studies, the dermal penetration of isotretinoin from microemulsions was investigated by tape stripping procedure. Confocal laser scanning microscopy provided insight about the localization of the drug in the skin. The interaction between the microemulsion components and stratum corneum lipids is studied by ATR-FTIR spectroscopy. The relative safety of the microemulsions was assessed in mouse embryonic fibroblasts using MTT viability test. The results indicate that microemulsion-based novel colloidal carriers have a potential for enhanced skin delivery and localization of isotretinoin.
机译:寻常痤疮是皮肤毛囊皮脂单位的慢性,多因素和复杂疾病。痤疮局部治疗的主要目的是通过使全身吸收减至最小,将药物靶向表皮和真皮深层。异维A酸是一种维甲酸衍生物,是痤疮发病中最有效的药物。因为全身治疗可能会引起许多副作用,所以局部异维A酸治疗是治疗痤疮的一种选择。然而,由于异维A酸的亲脂性高,它倾向于在角质层的上层积聚,因此其渗透到下层的能力受到限制,这限制了局部治疗的效率。微乳液是流体,各向同性的胶体药物载体,已被广泛研究为药物递送系统。与常规制剂相比,微乳剂可增强活性剂的经皮运输。这项研究的目的是评估微乳作为异维A酸的替代局部载体,目的是改善其皮肤吸收。在体外渗透研究之后,通过胶带剥离法研究了异维A酸从微乳中的透皮性。共聚焦激光扫描显微镜提供了有关药物在皮肤中定位的见解。通过ATR-FTIR光谱研究了微乳液组分与角质层脂质之间的相互作用。使用MTT生存力测试评估了小鼠胚胎成纤维细胞中微乳剂的相对安全性。结果表明,基于微乳液的新型胶体载体具有增强皮肤输送和异维A酸定位的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号